Hepatitis B, Chronic Clinical Trials

A listing of 4 Hepatitis B, Chronic clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Hepatitis B, Chronic

1 - 4 of 4

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 4 active clinical trials seeking participants for Hepatitis B, Chronic research studies. The states with the highest number of trials for Autism participants are California, Beijing, Guangdong and Jiangsu.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Healthy Volunteer Trials

Recruiting

Healthy volunteer trials near you are looking for participants to help push medical research forward. Click through to learn more!

Conditions:

Healthy

Healthy Volunteers

Learn More

The HOPE Study: Characterizing Patients With Hepatitis B and C

NCT02995252

Recruiting

This is an observational, longitudinal, prospective study for sample collection and evaluation for future therapy or disease progression of chronic hepatitis B and C. Participants will be seen on an annual basis with optional additional visits for up to 10 years and provide samples for research and evaluation of disease progression. In addition, there is a longitudinal sub-study for treatment of hepatitis B that will involve 2 years of treatment with tenofovir alafenamide and blood collections w... Read More

Gender:

All

Ages:

Between 18 years and 99 years

Trial Updated:

04/02/2024

Locations: Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland +1 locations

Conditions: Hepatitis B， Chronic, Hepatitis C

Learn More ›

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

NCT05867056

Recruiting

IMC-I109V is an immune-mobilizing monoclonal T cell receptor (TCR) against viruses (ImmTAV®), a new class of bispecific protein therapeutics designed for the treatment of chronic hepatitis B virus (HBV) infection (CHB). This is the first in-human study of IMC-I109V in persons with CHB.

Gender:

All

Ages:

Between 18 years and 65 years

Trial Updated:

03/15/2024

Locations: University of Southern California Keck School of Medicine, Los Angeles, California +14 locations

Conditions: Hepatitis B, Chronic

Learn More ›

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

NCT05630820

Recruiting

This study is intended to confirm the efficacy, safety, pharmacokinetic (PK) profile, and the durability of hepatitis B virus surface antigen (HBsAg) suppression observed with bepirovirsen for 24 weeks (with loading doses) as compared to the placebo arm. This study will have 4 stages: a) Double-blind treatment (bepirovirsen or placebo) for 24 weeks. b) Nucleos(t)ide analogue (NA) treatment for 24 weeks. c) NA cessation stage OR Continue NA for 24 weeks. d) Durability of response and follow up fo... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

02/29/2024

Locations: GSK Investigational Site, Centreville, Alabama +190 locations

GSK Investigational Site, Centreville, Alabama

GSK Investigational Site, Los Angeles, California

GSK Investigational Site, San Diego, California

GSK Investigational Site, San Francisco, California

GSK Investigational Site, Colorado Springs, Colorado

GSK Investigational Site, Fort Pierce, Florida

GSK Investigational Site, Miami, Florida

GSK Investigational Site, Glen Burnie, Maryland

GSK Investigational Site, Minneapolis, Minnesota

GSK Investigational Site, Philadelphia, Pennsylvania

GSK Investigational Site, Denison, Texas

GSK Investigational Site, Seattle, Washington

GSK Investigational Site, Cordoba, Córdova

GSK Investigational Site, Villa Regina, Río Negro

GSK Investigational Site, Buenos Aires, Not set

GSK Investigational Site, Rio Cuarto, Not set

GSK Investigational Site, Santa Fe, Not set

GSK Investigational Site, Westmead, New South Wales

GSK Investigational Site, Herston, Queensland

GSK Investigational Site, Box Hill, Victoria

GSK Investigational Site, Fitzroy, Victoria

GSK Investigational Site, Salvador, Bahia

GSK Investigational Site, Fortaleza, Ceará

GSK Investigational Site, Vitoria, Espirito Santo

GSK Investigational Site, Porto Alegre, Rio Grande Do Sul

GSK Investigational Site, Botucatu, São Paulo

GSK Investigational Site, Alto Da Posse, Nova Iguacu, Not set

GSK Investigational Site, Rio de Janeiro, Not set

GSK Investigational Site, Plovdiv, Not set

GSK Investigational Site, Sliven, Not set

GSK Investigational Site, Sofia, Not set

GSK Investigational Site, Varna, Not set

GSK Investigational Site, Calgary, Alberta

GSK Investigational Site, Edmonton, Alberta

GSK Investigational Site, Halifax, Nova Scotia

GSK Investigational Site, Toronto, Ontario

GSK Investigational Site, Montreal, Quebec

GSK Investigational Site, Regina, Saskatchewan

GSK Investigational Site, Hefei, Anhui

GSK Investigational Site, Guangzhou, Guangdong

GSK Investigational Site, Wuhan, Hubei

GSK Investigational Site, Nanjing, Jiangsu

GSK Investigational Site, Changchun, Jilin

GSK Investigational Site, Chengdu, Sichuan

GSK Investigational Site, Chongqing, Sichuan

GSK Investigational Site, Urumqi, Xinjiang

GSK Investigational Site, Kunming, Yunnan

GSK Investigational Site, Beijing, Not set

GSK Investigational Site, Guangzhou, Not set

GSK Investigational Site, Hangzhou, Not set

GSK Investigational Site, Liuzhou, Not set

GSK Investigational Site, Shanghai, Not set

GSK Investigational Site, Shenzhen, Not set

GSK Investigational Site, Taiyuan, Not set

GSK Investigational Site, Tianjin, Not set

GSK Investigational Site, Xi'an, Not set

GSK Investigational Site, Xiamen, Not set

GSK Investigational Site, Zhengzhou, Not set

GSK Investigational Site, Zunyi, Not set

GSK Investigational Site, Créteil cedex, Not set

GSK Investigational Site, Créteil Cedex, Not set

GSK Investigational Site, Grenoble cedex 9, Not set

GSK Investigational Site, Limoges cedex, Not set

GSK Investigational Site, Lyon cedex 04, Not set

GSK Investigational Site, Paris Cedex 13, Not set

GSK Investigational Site, Paris, Not set

GSK Investigational Site, Rouen cedex, Not set

GSK Investigational Site, Toulouse cedex 9, Not set

GSK Investigational Site, Frankfurt am Main, Hessen

GSK Investigational Site, Frankfurt, Hessen

GSK Investigational Site, Hannover, Niedersachsen

GSK Investigational Site, Hamburg, Not set

GSK Investigational Site, Athens, Not set

GSK Investigational Site, Heraklion, Not set

GSK Investigational Site, Kifisia, Not set

GSK Investigational Site, Thessaloniki, Not set

GSK Investigational Site, Szeged, Not set

GSK Investigational Site, Székesfehérvár, Not set

GSK Investigational Site, Zalaegerszeg, Not set

GSK Investigational Site, Raipur, Chhattisgarh

GSK Investigational Site, Ahmedabad, Gujarat

GSK Investigational Site, Mumbai, Maharashtra

GSK Investigational Site, Kolkata, West Bengal

GSK Investigational Site, Chennai, Not set

GSK Investigational Site, Haryana, Not set

GSK Investigational Site, Kanpur, Not set

GSK Investigational Site, Kochi, Not set

GSK Investigational Site, Kolkata, Not set

GSK Investigational Site, Nagpur, Not set

GSK Investigational Site, New Delhi, Not set

GSK Investigational Site, Pune, Not set

GSK Investigational Site, Secunderabad, Not set

GSK Investigational Site, Napoli, Campania

GSK Investigational Site, Roma, Lazio

GSK Investigational Site, Milano, Lombardia

GSK Investigational Site, Torino, Piemonte

GSK Investigational Site, Sassari, Sardegna

GSK Investigational Site, Palermo, Sicilia

GSK Investigational Site, Pisa, Toscana

GSK Investigational Site, Padova, Veneto

GSK Investigational Site, Fukui, Not set

GSK Investigational Site, Hiroshima, Not set

GSK Investigational Site, Hokkaido, Not set

GSK Investigational Site, Ishikawa, Not set

GSK Investigational Site, Kagawa, Not set

GSK Investigational Site, Kumamoto, Not set

GSK Investigational Site, Nagasaki, Not set

GSK Investigational Site, Nara, Not set

GSK Investigational Site, Niigata, Not set

GSK Investigational Site, Osaka, Not set

GSK Investigational Site, Tokyo, Not set

GSK Investigational Site, Yamaguchi, Not set

GSK Investigational Site, Yamanashi, Not set

GSK Investigational Site, Busan, Not set

GSK Investigational Site, Gyeonggi-do, Not set

GSK Investigational Site, Incheon, Not set

GSK Investigational Site, Seoul, Not set

GSK Investigational Site, Ulsan, Not set

GSK Investigational Site, Johor Bahru, Not set

GSK Investigational Site, Kota Bharu, Not set

GSK Investigational Site, Kota Kinabalu, Not set

GSK Investigational Site, Kuala Lumpur, Not set

GSK Investigational Site, Kuala Terengganu, Not set

GSK Investigational Site, Kuantan, Not set

GSK Investigational Site, Guadalajara, Jalisco

GSK Investigational Site, Monterrey, Nuevo León

GSK Investigational Site, Aguascalientes, Not set

GSK Investigational Site, Tlalnepantla, Not set

GSK Investigational Site, Auckland, Not set

GSK Investigational Site, Papatoetoe, Auckland, Not set

GSK Investigational Site, Panama, Not set

GSK Investigational Site, Silang, Cavite

GSK Investigational Site, Cebu City, Not set

GSK Investigational Site, Makati City, Not set

GSK Investigational Site, Pasig, Not set

GSK Investigational Site, Gdansk, Not set

GSK Investigational Site, Myslowice, Not set

GSK Investigational Site, Zychlin, Not set

GSK Investigational Site, Bucharest, Not set

GSK Investigational Site, Bucuresti, Not set

GSK Investigational Site, Cluj-Napoca, Not set

GSK Investigational Site, Constanta, Not set

GSK Investigational Site, Galati, Not set

GSK Investigational Site, Oradea, Not set

GSK Investigational Site, Singapore, Not set

GSK Investigational Site, Caceres / Caceres, Caceres / Extremadura

GSK Investigational Site, Alcorcon, Madrid

GSK Investigational Site, Almería, Not set

GSK Investigational Site, Badajoz, Not set

GSK Investigational Site, Granada, Not set

GSK Investigational Site, Madrid, Not set

GSK Investigational Site, Sabadell (Barcelona), Not set

GSK Investigational Site, Sevilla, Not set

GSK Investigational Site, Valencia, Not set

GSK Investigational Site, Valladolid, Not set

GSK Investigational Site, Zaragoza, Not set

GSK Investigational Site, Kaohsiung, Not set

GSK Investigational Site, Taichung, Not set

GSK Investigational Site, Tainan, Not set

GSK Investigational Site, Taipei, Not set

GSK Investigational Site, Chiangmai, Not set

GSK Investigational Site, Ankara, Not set

GSK Investigational Site, Istanbul, Not set

GSK Investigational Site, Izmir, Not set

GSK Investigational Site, Liverpool., Not set

GSK Investigational Site, London, Not set

GSK Investigational Site, Middlesbrough, Not set

GSK Investigational Site, Newcastle-upon-Tyne, Not set

GSK Investigational Site, Plymouth, Not set

GSK Investigational Site, Hanoi, Not set

GSK Investigational Site, Ho Chi Minh City, Not set

Conditions: Chronic Hepatitis B, Hepatitis B, Chronic

Learn More ›

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

NCT04856085

Recruiting

This is a phase 2 study in which participants with chronic hepatitis B virus (HBV) infection will receive VIR-2218, VIR-3434 and/or PEG-IFNα and be assessed for safety, tolerability, and efficacy

Gender:

All

Ages:

Between 18 years and 65 years

Trial Updated:

09/22/2023

Locations: Investigative Site, San Francisco, California +39 locations

Investigative Site, San Francisco, California

Investigative Site, Miami, Florida

Investigative Site, Orlando, Florida

Investigative Site, Baltimore, Maryland

Investigative Site, Hillsborough, New Jersey

Investigative Site, Toronto, Not set

Investigative Site, Vancouver, Not set

Investigative Site, Frankfurt, Not set

Investigative Site, Hannover, Not set

Investigative Site, Mannheim, Not set

Investigative Site, Ulm, Not set

Investigative Site, Hong Kong, Shatin

Investigative Site, Hong Kong, Tai Po

Investigative Site, Hong Kong, Not set

Investigative Site, Busan, Not set

Investigative Site, Seoul, Not set

Investigative Site, Yangsan, Not set

Investigative Site, Batu Caves, Not set

Investigative Site, Kajang, Not set

Investigative Site, Kuala Lumpur, Not set

Investigative Site, Chisinau, Not set

Investigative Site, Auckland, Not set

Investigative Site, Hamilton, Not set

Investigative Site, Tauranga, Not set

Investigative Site, Wellington, Not set

Investigative Site, Bucharest, Not set

Investigative Site, Chiayi City, Not set

Investigative Site, Kaohsiung City, Not set

Investigative Site, Taichung City, Not set

Investigative Site, Taipei City, Not set

Investigative Site, Taoyuan City, Not set

Investigative Site, Kyiv, Not set

Investigative Site, Birmingham, Not set

Investigative Site, London, Not set

Investigative Site, Manchester, Not set

Conditions: Hepatitis B, Chronic

Learn More ›

1 - 4 of 4